These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 2493180)

  • 1. Variable allograft responses to pretreatment with donor splenocytes treated with mitomycin C in the rat.
    Yamaguchi Y; Harland R; Wyble C; Mori K; Bollinger RR
    Transplantation; 1989 Feb; 47(2):360-3. PubMed ID: 2493180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of hepatic allograft rejection in the rat by mitomycin C-treated donor splenocytes: analysis of the immune status.
    Yamaguchi Y; Mori K; Bollinger RR
    J Clin Lab Immunol; 1990 Jun; 32(2):59-66. PubMed ID: 1967040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of donor splenocytes treated with mitomycin C on rat hepatic, cardiac, and intestinal allografts.
    Bollinger RB; Yamaguchi Y; Harland RC; Wyble C; Mori K
    Transplant Proc; 1989 Feb; 21(1 Pt 1):213-4. PubMed ID: 2495602
    [No Abstract]   [Full Text] [Related]  

  • 4. Suppression of hepatic allograft rejection in the rat by mitomycin C-treated donor splenocytes: in situ splenic distribution of donor class I major histocompatibility complex antigen-positive cells in the recipient.
    Goto M; Yamaguchi Y; Matsuno K; Takata N; Makino Y; Kikuchi N; Hamaguchi H; Hisama N; Miyanari N; Mori K; Ogawa M
    J Surg Res; 1996 Jan; 60(1):216-23. PubMed ID: 8592417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment of transfused donor splenocytes and allografts with mitomycin C attenuates acute rejection in heart transplantation in mice.
    Liu L; Wang F; Zheng Y; Yuan X; Wang D; Zeng W; He X; Wang C; Deng S
    Transplant Proc; 2014 May; 46(4):1169-74. PubMed ID: 24815153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Injection of mitomycin-C-treated spleen cells induces donor-specific unresponsiveness to cardiac allografts in rats.
    Tanigawa T; Gotoh M; Nagano H; Ota H; Fukuzaki T; Sakon M; Monden M
    Transplantation; 1999 Mar; 67(5):653-8. PubMed ID: 10096518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of class I major histocompatibility complex antigens in prolonging the survival of hepatic allografts in the rat.
    Yamaguchi Y; Harland RC; Wyble C; Bollinger RR
    Transplantation; 1989 Jan; 47(1):171-7. PubMed ID: 2643224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrathymic injection of donor alloantigens induces specific tolerance to cardiac allografts.
    Goss JA; Nakafusa Y; Yu S; Flye MW
    Transplantation; 1993 Jul; 56(1):166-73. PubMed ID: 8333039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-CD4 therapy in combined heart-kidney, heart-liver, and heart-small bowel allotransplants in high-responder rats.
    Yin DP; Sankary HN; Talor-Edwards C; Chong AS; Foster P; Shen J; Ma LL; Williams JW; Fathman CG
    Transplantation; 1998 Jul; 66(1):1-5. PubMed ID: 9679814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of donor-specific splenocytes via portal vein and FK506 in rat small bowel transplantation.
    Miyauchi T; Ishikawa M; Tashiro S; Hisaeda H; Nagasawa H; Himeno K
    Transplantation; 1998 Jan; 65(1):27-32. PubMed ID: 9448139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 15AU81, a prostacyclin analog, enhances donor-specific hepatocytes to prolong the survival of rat heart but not small bowel allografts.
    Boyle MJ; Dumble LJ
    Cell Transplant; 1999; 8(5):543-8. PubMed ID: 10580348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgG alloantibody responses to donor-specific blood transfusion in different rat strain combinations as a predictor of renal allograft survival.
    Wasowska B; Baldwin WM; Sanfilippo F
    Transplantation; 1992 Jan; 53(1):175-80. PubMed ID: 1370737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of donor-specific tolerance to cardiac but not skin or renal allografts by intrathymic injection of splenocyte alloantigen.
    Nakafusa Y; Goss JA; Mohanakumar T; Flye MW
    Transplantation; 1993 Apr; 55(4):877-82. PubMed ID: 8475563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of donor specific transplantation tolerance to cardiac allografts following treatment with nondepleting (RIB 5/2) or depleting (OX-38) anti-CD4 mAb plus intrathymic or intravenous donor alloantigen.
    Arima T; Lehmann M; Flye MW
    Transplantation; 1997 Jan; 63(2):284-92. PubMed ID: 9020332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of allochimeric proteins to mitigate graft-versus-host and host-versus-graft immune responses to rat small bowel allografts.
    Okamoto M; Stepkowski SM; Wang M; Kahan BD
    Transplantation; 2000 Oct; 70(7):1060-7. PubMed ID: 11045643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretransplant intrathymic inoculation of donor antigen combined with FK506 treatment: prolongation of survival of cardiac, but not renal, allografts in rats.
    Motoyama K; Kamei T; Arima T; Ueki M; Hirano T; Nakafusa Y; Tanaka M
    World J Surg; 1995; 19(2):299-302. PubMed ID: 7538717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathymic injection of donor alloantigens induces donor-specific vascularized allograft tolerance without immunosuppression.
    Goss JA; Nakafusa Y; Flye MW
    Ann Surg; 1992 Oct; 216(4):409-14; discussion 414-6. PubMed ID: 1417190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of donor-specific unresponsiveness to rat cardiac allograft by donor leukocytes and cyclosporine.
    Oluwole SF; Fawwaz RA; Reemtsma K; Hardy MA
    Transplantation; 1988 Jun; 45(6):1131-5. PubMed ID: 3289153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Permanent rat cardiac allograft survival induced by ultraviolet B-irradiated donor lymphocytes and peritransplant cyclosporine.
    Oluwole SF; Fawwaz RA; Reemtsma K; Hardy MA
    Surgery; 1988 Aug; 104(2):231-8. PubMed ID: 2969630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4(+)CD25(+) regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation.
    Pu LY; Wang XH; Zhang F; Li XC; Yao AH; Yu Y; Lv L; Li GQ
    Surgery; 2007 Jul; 142(1):67-73. PubMed ID: 17630002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.